{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T07:24:37Z","timestamp":1792481077626,"version":"4.5.0"},"reference-count":147,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T00:00:00Z","timestamp":1713916800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010877","name":"ViiV Healthcare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010877","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To develop consensus data statements and clinical recommendations to provide guidance for improving cardiometabolic health outcomes in people with HIV based on the knowledge and experience of an international panel of experts.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A targeted literature review including 281 conference presentations, peer-reviewed articles, and background references on cardiometabolic health in adults with HIV published between January 2016 and April 2022 was conducted and used to develop draft consensus data statements. Using a modified Delphi method, an international panel of 16 experts convened in workshops and completed surveys to refine consensus data statements and generate clinical recommendations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Overall, 10 data statements, five data gaps and 14 clinical recommendations achieved consensus. In the data statements, the panel describes increased risk of cardiometabolic health concerns in people with HIV compared with the general population, known risk factors, and the potential impact of antiretroviral therapy. The panel also identified data gaps to inform future research in people with HIV. Finally, in the clinical recommendations, the panel emphasizes the need for a holistic approach to comprehensive care that includes regular assessment of cardiometabolic health, access to cardiometabolic health services, counselling on potential changes in weight after initiating or switching antiretroviral therapy and encouraging a healthy lifestyle to lower cardiometabolic health risk.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>On the basis of available data and expert consensus, an international panel developed clinical recommendations to address the increased risk of cardiometabolic disorders in people with HIV to ensure appropriate cardiometabolic health management for this population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jac\/dkae116","type":"journal-article","created":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T18:47:57Z","timestamp":1712256477000},"page":"1218-1233","source":"Crossref","is-referenced-by-count":25,"title":["Cardiometabolic health in people with HIV: expert consensus review"],"prefix":"10.1093","volume":"79","author":[{"given":"Rachel L","family":"Batterham","sequence":"first","affiliation":[{"name":"UCL Division of Medicine, UCL School of Life and Medical Sciences, University College London , Gower Street, London WC1E 6BT , UK"},{"name":"University College London Hospitals Biomedical Research Centre , National Institute for Health and Care Research, Maple House Suite A 1st Floor, 149 Tottenham Court Road, London W1T 7DN , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger J","family":"Bedimo","sequence":"additional","affiliation":[{"name":"Infectious Disease Section, VA North Texas Health Care System , 4500 S Lancaster Road, Dallas, TX 75216 , USA"},{"name":"Internal Medicine, University of Texas Southwestern Medical Center , 5323 Harry Hines Boulevard, Dallas, TX 75390 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8395-7304","authenticated-orcid":false,"given":"Ricardo S","family":"Diaz","sequence":"additional","affiliation":[{"name":"Infectious Diseases Department, Paulista School of Medicine, Federal University of S\u00e3o Paulo , R. Sena Madureira, 1500 Vila Clementino, S\u00e3o Paulo, 04021-001 , Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5724-3914","authenticated-orcid":false,"given":"Giovanni","family":"Guaraldi","sequence":"additional","affiliation":[{"name":"Modena HIV Metabolic Clinic, University of Modena and Reggio Emilia , Via Universit\u00e0 4, 41121 Modena , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5678-6140","authenticated-orcid":false,"given":"Janet","family":"Lo","sequence":"additional","affiliation":[{"name":"Department of Medicine, Massachusetts General Hospital , 55 Fruit Street, Boston, MA 02114 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6911-8846","authenticated-orcid":false,"given":"Esteban","family":"Mart\u00ednez","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit, Hospital Clinic and University of Barcelona , C. de Villarroel, 170, 08036 Barcelona , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace A","family":"McComsey","sequence":"additional","affiliation":[{"name":"Case Center for Diabetes, Obesity and Metabolism, School of Medicine, Case Western Reserve University , 10900 Euclid Avenue, Cleveland, OH 44106 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Milinkovic","sequence":"additional","affiliation":[{"name":"Global Medical, ViiV Healthcare , 980 Great West Road, Brentford, Middlesex TW8 9GS , UK"},{"name":"HIV Services, Chelsea and Westminster Hospital , 369 Fulham Road, London SW10 9NH , UK"},{"name":"Imperial College London , Exhibition Road, South Kensington, London SW7 2BX , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshio","family":"Naito","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Juntendo University Faculty of Medicine , 2 Chome-1-1 Hongo, Bunkyo City, Tokyo 113-8421 , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Noe","sequence":"additional","affiliation":[{"name":"MVZ Karlsplatz , MVZ Karlsplatz 8, 80335, Munich , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donal","family":"O\u2019Shea","sequence":"additional","affiliation":[{"name":"Health Sciences Centre, University College Dublin School of Medicine , Belfield, Dublin 4 , Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Paredes","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Hospital Universitari Germans Trias i Pujol , Carretera de Canyet, s\/n, 08916 Badalona, Barcelona , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan M","family":"Schapiro","sequence":"additional","affiliation":[{"name":"National Hemophilia Center, Sheba Medical Center , Derech Sheba 2, Ramat Gan, Tel Aviv , Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark S","family":"Sulkowski","sequence":"additional","affiliation":[{"name":"Department of Medicine, Johns Hopkins University School of Medicine , 733 N Broadway, Baltimore, MD 21205 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4157-732X","authenticated-orcid":false,"given":"Fran\u00e7ois","family":"Venter","sequence":"additional","affiliation":[{"name":"Ezintsha, University of the Witwatersrand , 1 Jan Smuts Avenue, Braamfontein 2000, Johannesburg , South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Waters","sequence":"additional","affiliation":[{"name":"Mortimer Market Centre, Central and North West London NHS Foundation Trust , 350 Euston Road, Regent's Place, London NW1 3AX , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilksen Ungan","family":"Yoruk","sequence":"additional","affiliation":[{"name":"General Medicines Europe, GSK , 980 Great West Road, Brentford, Middlesex TW8 9GS , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Young","sequence":"additional","affiliation":[{"name":"Global Medical, ViiV Healthcare , 406 Blackwell Street, Suite 300, Durham, NC 27701 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,4,24]]},"reference":[{"key":"2024060223524129500_dkae116-B1","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/S0140-6736(13)61809-7","article-title":"The end of AIDS: HIV infection as a chronic disease","volume":"382","author":"Deeks","year":"2013","journal-title":"Lancet"},{"key":"2024060223524129500_dkae116-B2","author":"World Health Organization"},{"key":"2024060223524129500_dkae116-B3","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12916-016-0640-4","article-title":"Beyond viral suppression of HIV\u2014the new quality of life frontier","volume":"14","author":"Lazarus","year":"2016","journal-title":"BMC Med"},{"key":"2024060223524129500_dkae116-B4","doi-asserted-by":"crossref","first-page":"865","DOI":"10.3389\/fphys.2017.00865","article-title":"Improving cardiometabolic health with diet, physical activity, and breaking up sitting: what about sleep?","volume":"8","author":"Vincent","year":"2017","journal-title":"Front Physiol"},{"key":"2024060223524129500_dkae116-B5","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.3390\/ijms20092358","article-title":"Adipose tissue dysfunction as determinant of obesity-associated metabolic complications","volume":"20","author":"Longo","year":"2019","journal-title":"Int J Mol Sci"},{"key":"2024060223524129500_dkae116-B6","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1093\/infdis\/jiz118","article-title":"Obesity and fat metabolism in human immunodeficiency virus-infected individuals: immunopathogenic mechanisms and clinical implications","volume":"220","author":"Godfrey","year":"2019","journal-title":"J Infect Dis"},{"key":"2024060223524129500_dkae116-B7","doi-asserted-by":"crossref","first-page":"106493","DOI":"10.1016\/j.ijantimicag.2021.106493","article-title":"Management of comorbidities in treated HIV infection: a long way to go: HIV, comorbidities and aging","volume":"59","author":"Mart\u00ednez-Sanz","year":"2022","journal-title":"Int J Antimicrob Agents"},{"key":"2024060223524129500_dkae116-B8","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1097\/QAI.0000000000002629","article-title":"Human immunodeficiency virus infection and incident heart failure: a meta-analysis of prospective studies","volume":"87","author":"Chen","year":"2021","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2024060223524129500_dkae116-B9","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1093\/infdis\/jiab420","article-title":"Incidence of cardiometabolic diseases in people with and without human immunodeficiency virus in the United Kingdom: a population-based matched cohort study","volume":"225","author":"Gooden","year":"2022","journal-title":"J Infect Dis"},{"key":"2024060223524129500_dkae116-B10","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3851\/IMP3298","article-title":"Cardiovascular disease incidence projections in the TREAT Asia HIV Observational Database (TAHOD)","volume":"24","author":"Bijker","year":"2019","journal-title":"Antivir Ther"},{"key":"2024060223524129500_dkae116-B11","first-page":"10","article-title":"The Delphi technique: making sense of consensus","volume":"12","author":"Hsu","year":"2007","journal-title":"Pract Assess Res Eval"},{"key":"2024060223524129500_dkae116-B12","author":"World Health Organization"},{"key":"2024060223524129500_dkae116-B13","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.metabol.2018.09.005","article-title":"The epidemiology of obesity","volume":"92","author":"Chooi","year":"2019","journal-title":"Metabolism"},{"key":"2024060223524129500_dkae116-B14","doi-asserted-by":"crossref","first-page":"e1003198","DOI":"10.1371\/journal.pmed.1003198","article-title":"The global burden of disease attributable to high body mass index in 195 countries and territories, 1990\u20132017: an analysis of the Global Burden of Disease Study","volume":"17","author":"Dai","year":"2020","journal-title":"PLoS Med"},{"key":"2024060223524129500_dkae116-B15","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1089\/aid.2015.0147","article-title":"Rising obesity prevalence and weight gain among adults starting antiretroviral therapy in the United States and Canada","volume":"32","author":"Koethe","year":"2016","journal-title":"AIDS Res Hum Retroviruses"},{"key":"2024060223524129500_dkae116-B16","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1093\/cid\/civ192","article-title":"Weight change after antiretroviral therapy and mortality","volume":"60","author":"Yuh","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2024060223524129500_dkae116-B17","doi-asserted-by":"crossref","first-page":"ofab542","DOI":"10.1093\/ofid\/ofab542","article-title":"Excess weight gain with integrase inhibitors and tenofovir alafenamide: what is the mechanism and does it matter?","volume":"8","author":"Wood","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"2024060223524129500_dkae116-B18","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1089\/aid.2012.0234","article-title":"Short communication: from wasting to obesity: initial antiretroviral therapy and weight gain in HIV-infected persons","volume":"29","author":"Lakey","year":"2013","journal-title":"AIDS Res Hum Retroviruses"},{"key":"2024060223524129500_dkae116-B19","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1097\/QAD.0000000000001248","article-title":"Long-term body composition changes in antiretroviral-treated HIV-infected individuals","volume":"30","author":"Grant","year":"2016","journal-title":"AIDS"},{"key":"2024060223524129500_dkae116-B20","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1093\/cid\/ciw017","article-title":"Body composition changes after initiation of raltegravir or protease inhibitors: ACTG A5260s","volume":"62","author":"McComsey","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2024060223524129500_dkae116-B21","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1093\/cid\/ciz407","article-title":"Greater weight gain in treatment-naive persons starting dolutegravir-based antiretroviral therapy","volume":"70","author":"Bourgi","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2024060223524129500_dkae116-B22","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/QAI.0000000000002556","article-title":"Brief report: weight gain following ART initiation in ART-na\u00efve people living with HIV in the current treatment era","volume":"86","author":"Ruderman","year":"2021","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2024060223524129500_dkae116-B23","doi-asserted-by":"crossref","first-page":"e666","DOI":"10.1016\/S2352-3018(20)30241-1","article-title":"Dolutegravir with emtricitabine and tenofovir alafenamide or tenofovir disoproxil fumarate versus efavirenz, emtricitabine, and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection (ADVANCE): week 96 results from a randomised, phase 3, non-inferiority trial","volume":"7","author":"Venter","year":"2020","journal-title":"Lancet HIV"},{"key":"2024060223524129500_dkae116-B24","doi-asserted-by":"crossref","first-page":"e711","DOI":"10.1016\/S2352-3018(21)00163-6","article-title":"Contemporary antiretrovirals and body-mass index: a prospective study of the RESPOND cohort consortium","volume":"8","author":"Bansi-Matharu","year":"2021","journal-title":"Lancet HIV"},{"key":"2024060223524129500_dkae116-B25","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1093\/cid\/ciz999","article-title":"Weight gain following initiation of antiretroviral therapy: risk factors in randomized comparative clinical trials","volume":"71","author":"Sax","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2024060223524129500_dkae116-B26","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/QAI.0000000000003087","article-title":"Weight gain among treatment-na\u00efve persons with HIV receiving dolutegravir in Kenya","volume":"91","author":"Bourgi","year":"2022","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2024060223524129500_dkae116-B27","doi-asserted-by":"crossref","first-page":"e25732","DOI":"10.1002\/jia2.25732","article-title":"Weight changes after antiretroviral therapy initiation in CoRIS (Spain): a prospective multicentre cohort study","volume":"24","author":"Mart\u00ednez-Sanz","year":"2021","journal-title":"J Int AIDS Soc"},{"key":"2024060223524129500_dkae116-B28","doi-asserted-by":"crossref","first-page":"e471","DOI":"10.1093\/cid\/ciaa177","article-title":"Risk factors for weight gain following switch to integrase inhibitor-based antiretroviral therapy","volume":"71","author":"Lake","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2024060223524129500_dkae116-B29","first-page":"100173","article-title":"Weight gain post-ART in HIV+ Latinos\/as differs in the USA, Haiti, and Latin America","volume":"8","author":"Coelho","year":"2022","journal-title":"Lancet Reg Health Am"},{"key":"2024060223524129500_dkae116-B30","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jchf.2018.10.006","article-title":"Cardiac dysfunction among people living with HIV: a systematic review and meta-analysis","volume":"7","author":"Erqou","year":"2019","journal-title":"JACC Heart Fail"},{"key":"2024060223524129500_dkae116-B31","doi-asserted-by":"crossref","first-page":"e0176686","DOI":"10.1371\/journal.pone.0176686","article-title":"HIV infection as vascular risk: a systematic review of the literature and meta-analysis","volume":"12","author":"Gutierrez","year":"2017","journal-title":"PLoS ONE"},{"key":"2024060223524129500_dkae116-B32","doi-asserted-by":"crossref","first-page":"e025874","DOI":"10.1136\/bmjopen-2018-025874","article-title":"Risk of myocardial infarction among people living with HIV: an updated systematic review and meta-analysis","volume":"9","author":"Eyawo","year":"2019","journal-title":"BMJ Open"},{"key":"2024060223524129500_dkae116-B33","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1080\/03007995.2021.2003671","article-title":"Comorbid diseases and conditions in people with HIV in the UK","volume":"38","author":"Jones","year":"2022","journal-title":"Curr Med Res Opin"},{"key":"2024060223524129500_dkae116-B34","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/hiv.12689","article-title":"Cardiovascular disease and diabetes in HIV-positive and HIV-negative gay and bisexual men over the age of 55 years in Australia: insights from the Australian Positive & Peers Longevity Evaluation Study","volume":"20","author":"Puhr","year":"2019","journal-title":"HIV Med"},{"key":"2024060223524129500_dkae116-B35","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1017\/S0950268818002339","article-title":"Incidence of cardiovascular diseases in a nationwide HIV\/AIDS patient cohort in Taiwan from 2000 to 2014","volume":"146","author":"Lai","year":"2018","journal-title":"Epidemiol Infect"},{"key":"2024060223524129500_dkae116-B36","doi-asserted-by":"crossref","first-page":"e021268","DOI":"10.1161\/JAHA.121.021268","article-title":"HIV infection and the risk of World Health Organization-defined sudden cardiac death","volume":"10","author":"Freiberg","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"2024060223524129500_dkae116-B37","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/QAI.0000000000000009","article-title":"Immunodeficiency and risk of myocardial infarction among HIV-positive individuals with access to care","volume":"65","author":"Silverberg","year":"2014","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2024060223524129500_dkae116-B38","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1001\/jamacardio.2017.0264","article-title":"Association between HIV infection and the risk of heart failure with reduced ejection fraction and preserved ejection fraction in the antiretroviral therapy era: results from the Veterans Aging Cohort Study","volume":"2","author":"Freiberg","year":"2017","journal-title":"JAMA Cardiol"},{"key":"2024060223524129500_dkae116-B39","doi-asserted-by":"crossref","first-page":"e009985","DOI":"10.1161\/JAHA.118.009985","article-title":"Adjudicated heart failure in HIV-infected and uninfected men and women","volume":"7","author":"Feinstein","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"2024060223524129500_dkae116-B40","doi-asserted-by":"crossref","first-page":"e279","DOI":"10.1016\/S2352-3018(20)30036-9","article-title":"HIV and cardiovascular disease","volume":"7","author":"So-Armah","year":"2020","journal-title":"Lancet HIV"},{"key":"2024060223524129500_dkae116-B41","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1093\/eurheartj\/ehy163","article-title":"Subclinical coronary artery disease in Swiss HIV-positive and HIV-negative persons","volume":"39","author":"Tarr","year":"2018","journal-title":"Eur Heart J"},{"key":"2024060223524129500_dkae116-B42","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1097\/QAI.0000000000002721","article-title":"Associations of hepatosteatosis with cardiovascular disease in HIV-positive and HIV-negative patients: the Liverpool HIV-Heart Project","volume":"87","author":"Heseltine","year":"2021","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2024060223524129500_dkae116-B43","doi-asserted-by":"crossref","first-page":"40","DOI":"10.11604\/pamj.2017.27.40.9840","article-title":"Cardiometabolic risk among HIV-positive Ugandan adults: prevalence, predictors and effect of long-term antiretroviral therapy","volume":"27","author":"Kazooba","year":"2017","journal-title":"Pan Afr Med J"},{"key":"2024060223524129500_dkae116-B44","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s11904-020-00483-5","article-title":"Obesity and weight gain in persons with HIV","volume":"17","author":"Bailin","year":"2020","journal-title":"Curr HIV\/AIDS Rep"},{"key":"2024060223524129500_dkae116-B45","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1093\/cid\/civ325","article-title":"HIV infection is associated with progression of subclinical carotid atherosclerosis","volume":"61","author":"Hanna","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2024060223524129500_dkae116-B46","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1001\/jamainternmed.2013.3728","article-title":"HIV infection and the risk of acute myocardial infarction","volume":"173","author":"Freiberg","year":"2013","journal-title":"JAMA Intern Med"},{"key":"2024060223524129500_dkae116-B47","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/hiv.13274","article-title":"Dangerous liaisons: NAFLD and liver fibrosis increase cardiovascular risk in HIV","volume":"23","author":"Cervo","year":"2022","journal-title":"HIV Med"},{"key":"2024060223524129500_dkae116-B48","first-page":"119","article-title":"Cardiovascular risk factors and HIV disease","volume":"13","author":"Fedele","year":"2011","journal-title":"AIDS Rev"},{"key":"2024060223524129500_dkae116-B49","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1056\/NEJMoa062360","article-title":"CD4+ count-guided interruption of antiretroviral treatment","volume":"355","author":"El-Sadr","year":"2006","journal-title":"N Engl J Med"},{"key":"2024060223524129500_dkae116-B50","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1097\/QAD.0b013e328300581d","article-title":"Low CD4+ T-cell count as a major atherosclerosis risk factor in HIV-infected women and men","volume":"22","author":"Kaplan","year":"2008","journal-title":"AIDS"},{"key":"2024060223524129500_dkae116-B51","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.ijantimicag.2018.07.010","article-title":"Risk of cardiovascular disease associated with exposure to abacavir among individuals with HIV: a systematic review and meta-analyses of results from 17 epidemiologic studies","volume":"52","author":"Dorjee","year":"2018","journal-title":"Int J Antimicrob Agents"},{"key":"2024060223524129500_dkae116-B52","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1086\/649897","article-title":"Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: the data collection on adverse events of anti-HIV drugs (D:A:D) study","volume":"201","author":"Worm","year":"2010","journal-title":"J Infect Dis"},{"key":"2024060223524129500_dkae116-B53","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/QAD.0000000000003373","article-title":"Recent abacavir use and incident cardiovascular disease in contemporary-treated people with HIV","volume":"37","author":"Jaschinski","year":"2023","journal-title":"AIDS"},{"key":"2024060223524129500_dkae116-B54","doi-asserted-by":"crossref","first-page":"ofy086","DOI":"10.1093\/ofid\/ofy086","article-title":"Abacavir use and risk for myocardial infarction and cardiovascular events: pooled analysis of data from clinical trials","volume":"5","author":"Nan","year":"2018","journal-title":"Open Forum Infect Dis"},{"key":"2024060223524129500_dkae116-B55","doi-asserted-by":"crossref","first-page":"e291","DOI":"10.1016\/S2352-3018(18)30043-2","article-title":"Cardiovascular disease and use of contemporary protease inhibitors: the D:A:D international prospective multicohort study","volume":"5","author":"Ryom","year":"2018","journal-title":"Lancet HIV"},{"key":"2024060223524129500_dkae116-B56","doi-asserted-by":"crossref","first-page":"e000304","DOI":"10.1136\/bmjdrc-2016-000304","article-title":"Is diabetes prevalence higher among HIV-infected individuals compared with the general population? Evidence from MMP and NHANES 2009\u20132010","volume":"5","author":"Hernandez-Romieu","year":"2017","journal-title":"BMJ Open Diabetes Res Care"},{"key":"2024060223524129500_dkae116-B57","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.3390\/jpm11111085","article-title":"Standardized comparison of cardiovascular risk factors prevalence in Spanish women and men living with HIV and in the general population","volume":"11","author":"Camps-Vilar\u00f3","year":"2021","journal-title":"J Pers Med"},{"key":"2024060223524129500_dkae116-B58","doi-asserted-by":"crossref","first-page":"676979","DOI":"10.3389\/fmed.2021.676979","article-title":"Association of HIV-1 infection and antiretroviral therapy with type 2 diabetes in the Hispanic population of the Rio Grande Valley, Texas, USA","volume":"8","author":"Lopez-Alvarenga","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"2024060223524129500_dkae116-B59","doi-asserted-by":"crossref","first-page":"e048744","DOI":"10.1136\/bmjopen-2021-048744","article-title":"Incidence of diabetes mellitus among people living with and without HIV in British Columbia, Canada between 2001 and 2013: a longitudinal population-based cohort study","volume":"11","author":"Bratu","year":"2021","journal-title":"BMJ Open"},{"key":"2024060223524129500_dkae116-B60","doi-asserted-by":"crossref","first-page":"e013953","DOI":"10.1136\/bmjopen-2016-013953","article-title":"Incidence and prevalence of type 2 diabetes mellitus with HIV infection in Africa: a systematic review and meta-analysis","volume":"7","author":"Prioreschi","year":"2017","journal-title":"BMJ Open"},{"key":"2024060223524129500_dkae116-B61","doi-asserted-by":"crossref","first-page":"e000457","DOI":"10.1136\/bmjdrc-2017-000457","article-title":"Incidence of diabetes mellitus and factors associated with its development in HIV-positive patients over the age of 50","volume":"5","author":"Samad","year":"2017","journal-title":"BMJ Open Diabetes Res Care"},{"key":"2024060223524129500_dkae116-B62","doi-asserted-by":"crossref","first-page":"e00292","DOI":"10.1002\/edm2.292","article-title":"Increased risk of prediabetes among virally suppressed adults with HIV in Central Kenya detected using glycated haemoglobin and fasting blood glucose","volume":"4","author":"Njoroge","year":"2021","journal-title":"Endocrinol Diabetes Metab"},{"key":"2024060223524129500_dkae116-B63","doi-asserted-by":"crossref","first-page":"101608","DOI":"10.1016\/j.bjid.2021.101608","article-title":"Incidence and associated factors of type 2 diabetes mellitus onset in the Brazilian HIV\/AIDS cohort study","volume":"25","author":"Cassenote","year":"2021","journal-title":"Braz J Infect Dis"},{"key":"2024060223524129500_dkae116-B64","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/hiv.13007","article-title":"Prevalence and incidence of pre-diabetes and diabetes mellitus among people living with HIV in Ghana: evidence from the EVERLAST study","volume":"22","author":"Sarfo","year":"2021","journal-title":"HIV Med"},{"key":"2024060223524129500_dkae116-B65","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/EDE.0000000000000815","article-title":"Incidence and risk factors for prediabetes and diabetes mellitus among HIV-infected adults on antiretroviral therapy: a systematic review and meta-analysis","volume":"29","author":"Nansseu","year":"2018","journal-title":"Epidemiology"},{"key":"2024060223524129500_dkae116-B66","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.bjid.2018.03.006","article-title":"Lipid accumulation product index in HIV-infected patients: a marker of cardiovascular risk","volume":"22","author":"Guimar\u00e3es","year":"2018","journal-title":"Braz J Infect Dis"},{"key":"2024060223524129500_dkae116-B67","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.2337\/dc16-1728","article-title":"Physical activity\/exercise and diabetes: a position statement of the American Diabetes Association","volume":"39","author":"Colberg","year":"2016","journal-title":"Diabetes Care"},{"key":"2024060223524129500_dkae116-B68","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s12916-017-0901-x","article-title":"Environmental\/lifestyle factors in the pathogenesis and prevention of type 2 diabetes","volume":"15","author":"Kolb","year":"2017","journal-title":"BMC Med"},{"key":"2024060223524129500_dkae116-B69","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1056\/NEJMoa010492","article-title":"Diet, lifestyle, and the risk of type 2 diabetes mellitus in women","volume":"345","author":"Hu","year":"2001","journal-title":"N Engl J Med"},{"key":"2024060223524129500_dkae116-B70","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s11892-018-1076-3","article-title":"Diabetes and HIV","volume":"18","author":"Noubissi","year":"2018","journal-title":"Curr Diab Rep"},{"key":"2024060223524129500_dkae116-B71","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J Hepatol"},{"key":"2024060223524129500_dkae116-B72","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"key":"2024060223524129500_dkae116-B73","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1177\/0956462420960997","article-title":"Prevalence and predicting factors of metabolic-associated fatty liver disease diagnosed by transient elastography with controlled attenuation parameters in HIV-positive people","volume":"32","author":"Jongraksak","year":"2021","journal-title":"Int J STD AIDS"},{"key":"2024060223524129500_dkae116-B74","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1111\/jgh.15320","article-title":"Prevalence and risk factors of metabolic associated fatty liver disease among people living with HIV in China","volume":"36","author":"Liu","year":"2021","journal-title":"J Gastroenterol Hepatol"},{"key":"2024060223524129500_dkae116-B75","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1093\/infdis\/jiaa246","article-title":"Prevalence and risk factors of moderate-to-severe hepatic steatosis in human immunodeficiency virus infection: the Copenhagen Co-morbidity Liver Study","volume":"222","author":"Kirkegaard-Klitbo","year":"2020","journal-title":"J Infect Dis"},{"key":"2024060223524129500_dkae116-B76","doi-asserted-by":"crossref","first-page":"e25201","DOI":"10.1002\/jia2.25201","article-title":"Predictive factors associated with liver fibrosis and steatosis by transient elastography in patients with HIV mono-infection under long-term combined antiretroviral therapy","volume":"21","author":"Perazzo","year":"2018","journal-title":"J Int AIDS Soc"},{"key":"2024060223524129500_dkae116-B77","doi-asserted-by":"crossref","first-page":"101116","DOI":"10.1016\/j.eclinm.2021.101116","article-title":"Stratifying the risk of NAFLD in patients with HIV under combination antiretroviral therapy (cART)","volume":"40","author":"Bischoff","year":"2021","journal-title":"EClinicalMedicine"},{"key":"2024060223524129500_dkae116-B78","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2174\/1570162X19666210225085002","article-title":"Transient elastography in HIV infected patients with liver steatosis identifies a high-risk group for non-alcoholic steatohepatitis","volume":"19","author":"Pezzini","year":"2021","journal-title":"Curr HIV Res"},{"key":"2024060223524129500_dkae116-B79","doi-asserted-by":"crossref","first-page":"155573","DOI":"10.1016\/j.cyto.2021.155573","article-title":"Changes in liver steatosis in HIV-positive women are associated with the BMI, but not with biomarkers","volume":"144","author":"Fernandez-Botran","year":"2021","journal-title":"Cytokine"},{"key":"2024060223524129500_dkae116-B80","doi-asserted-by":"crossref","first-page":"274","DOI":"10.5582\/bst.2017.01071","article-title":"Liver fibrosis after antiretroviral therapy in a longitudinal cohort of sexually infected HIV patients in eastern China","volume":"11","author":"Wei","year":"2017","journal-title":"Biosci Trends"},{"key":"2024060223524129500_dkae116-B81","doi-asserted-by":"crossref","first-page":"e0190302","DOI":"10.1371\/journal.pone.0190302","article-title":"HIV-1 co-receptor tropism and liver fibrosis in HIV-infected patients","volume":"13","author":"Saracino","year":"2018","journal-title":"PLoS ONE"},{"key":"2024060223524129500_dkae116-B82","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3851\/IMP2979","article-title":"Low bone mineral density and risk of incident fracture in HIV-infected adults","volume":"21","author":"Battalora","year":"2016","journal-title":"Antivir Ther"},{"key":"2024060223524129500_dkae116-B83","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s11657-021-00903-y","article-title":"People with HIV infection had lower bone mineral density and increased fracture risk: a meta-analysis","volume":"16","author":"Chang","year":"2021","journal-title":"Arch Osteoporos"},{"key":"2024060223524129500_dkae116-B84","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s00198-017-4305-8","article-title":"Reduced bone mineral density in human immunodeficiency virus-infected individuals: a meta-analysis of its prevalence and risk factors","volume":"29","author":"Goh","year":"2018","journal-title":"Osteoporos Int"},{"key":"2024060223524129500_dkae116-B85","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/cid\/ciab874","article-title":"Human immunodeficiency virus (HIV) and menopause are independently associated with lower bone mineral density: results from the Women's Interagency HIV Study","volume":"75","author":"Sharma","year":"2022","journal-title":"Clin Infect Dis"},{"key":"2024060223524129500_dkae116-B86","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/jbmr.4765","article-title":"The impact of human immunodeficiency virus and menopause on bone mineral density: a longitudinal study of urban-dwelling South African women","volume":"38","author":"Madanhire","year":"2023","journal-title":"J Bone Miner Res"},{"key":"2024060223524129500_dkae116-B87","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1097\/QAD.0000000000001372","article-title":"Predictors of longitudinal change in bone mineral density in a cohort of HIV-positive and negative patients","volume":"31","author":"Tinago","year":"2017","journal-title":"AIDS"},{"key":"2024060223524129500_dkae116-B88","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/QAI.0000000000002245","article-title":"Prevalence of and risk factors for low bone mineral density assessed by quantitative computed tomography in people living with HIV and uninfected controls","volume":"83","author":"Thomsen","year":"2020","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2024060223524129500_dkae116-B89","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1093\/jac\/dky201","article-title":"High risk and probability of progression to osteoporosis at 10 years in HIV-infected individuals: the role of PIs","volume":"73","author":"Negredo","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"2024060223524129500_dkae116-B90","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00198-020-05584-w","article-title":"Longitudinal change in bone mineral density among Chinese individuals with HIV after initiation of antiretroviral therapy","volume":"32","author":"Guo","year":"2021","journal-title":"Osteoporos Int"},{"key":"2024060223524129500_dkae116-B91","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11657-021-00890-0","article-title":"Long-term trabecular bone score and bone mineral density changes in Chinese antiretroviral-treated HIV-infected individuals","volume":"16","author":"Guan","year":"2021","journal-title":"Arch Osteoporos"},{"key":"2024060223524129500_dkae116-B92","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/QAI.0000000000001591","article-title":"Bone mineral density declines twice as quickly among HIV-infected women compared with men","volume":"77","author":"Erlandson","year":"2018","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2024060223524129500_dkae116-B93","doi-asserted-by":"crossref","first-page":"e0213440","DOI":"10.1371\/journal.pone.0213440","article-title":"Assessment of trabecular bone score, an index of bone microarchitecture, in HIV positive and HIV negative persons within the HIV UPBEAT cohort","volume":"14","author":"McGinty","year":"2019","journal-title":"PLoS ONE"},{"key":"2024060223524129500_dkae116-B94","doi-asserted-by":"crossref","first-page":"e0230368","DOI":"10.1371\/journal.pone.0230368","article-title":"Bone mineral density changes among people living with HIV who have started with TDF-containing regimen: a five-year prospective study","volume":"15","author":"Han","year":"2020","journal-title":"PLoS ONE"},{"key":"2024060223524129500_dkae116-B95","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1097\/QAD.0000000000001995","article-title":"Women have enhanced bone loss associated with phosphaturia and CD4+ cell restoration during initial antiretroviral therapy","volume":"32","author":"Kalayjian","year":"2018","journal-title":"AIDS"},{"key":"2024060223524129500_dkae116-B96","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1086\/656412","article-title":"Bone disease in HIV infection: a practical review and recommendations for HIV care providers","volume":"51","author":"McComsey","year":"2010","journal-title":"Clin Infect Dis"},{"key":"2024060223524129500_dkae116-B97","doi-asserted-by":"crossref","first-page":"S391","DOI":"10.1093\/infdis\/jis199","article-title":"Bone loss in the HIV-infected patient: evidence, clinical implications, and treatment strategies","volume":"205","author":"Walker Harris","year":"2012","journal-title":"J Infect Dis"},{"key":"2024060223524129500_dkae116-B98","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s40618-021-01665-7","article-title":"Impact of hypogonadism on bone mineral density and vertebral fractures in HIV-infected men","volume":"45","author":"Pezzaioli","year":"2022","journal-title":"J Endocrinol Invest"},{"key":"2024060223524129500_dkae116-B99","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1007\/s00198-021-05900-y","article-title":"The clinician's guide to prevention and treatment of osteoporosis","volume":"33","author":"LeBoff","year":"2022","journal-title":"Osteoporos Int"},{"key":"2024060223524129500_dkae116-B100","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/COH.0000000000000259","article-title":"Hepatitis C virus coinfection as a risk factor for osteoporosis and fracture","volume":"11","author":"Bedimo","year":"2016","journal-title":"Curr Opin HIV AIDS"},{"key":"2024060223524129500_dkae116-B101","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1002\/jbmr.3183","article-title":"Immediate initiation of antiretroviral therapy for HIV infection accelerates bone loss relative to deferring therapy: findings from the START bone mineral density substudy, a randomized trial","volume":"32","author":"Hoy","year":"2017","journal-title":"J Bone Miner Res"},{"key":"2024060223524129500_dkae116-B102","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1089\/aid.2018.0297","article-title":"Impact of estimated pre-exposure prophylaxis (PrEP) adherence patterns on bone mineral density in a large PrEP demonstration project","volume":"35","author":"Spinelli","year":"2019","journal-title":"AIDS Res Hum Retroviruses"},{"key":"2024060223524129500_dkae116-B103","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1093\/jac\/dkab400","article-title":"Bone changes with candidate PrEP regimens containing tenofovir disoproxil fumarate and\/or maraviroc and\/or emtricitabine in US men and women: HPTN 069\/ACTG A5305","volume":"77","author":"Brown","year":"2022","journal-title":"J Antimicrob Chemother"},{"key":"2024060223524129500_dkae116-B104","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1097\/QAI.0b013e3181adce44","article-title":"Loss of bone mineral density after antiretroviral therapy initiation, independent of antiretroviral regimen","volume":"51","author":"Brown","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2024060223524129500_dkae116-B105","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1097\/QAD.0b013e328328f789","article-title":"Greater decrease in bone mineral density with protease inhibitor regimens compared with nonnucleoside reverse transcriptase inhibitor regimens in HIV-1 infected naive patients","volume":"23","author":"Duvivier","year":"2009","journal-title":"AIDS"},{"key":"2024060223524129500_dkae116-B106","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/25787489.2020.1844520","article-title":"Week 96 subgroup analyses of the phase 3, randomized AMBER and EMERALD trials evaluating the efficacy and safety of the once daily darunavir\/cobicistat\/emtricitabine\/tenofovir alafenamide (D\/C\/F\/TAF) single-tablet regimen in antiretroviral treatment (ART)-na\u00efve and -experienced, virologically-suppressed adults living with HIV-1","volume":"21","author":"Huhn","year":"2020","journal-title":"HIV Res Clin Pract"},{"key":"2024060223524129500_dkae116-B107","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.2147\/IDR.S260449","article-title":"Bone safety of dolutegravir-containing regimens in people living with HIV: results from a real-world cohort","volume":"13","author":"Bonfanti","year":"2020","journal-title":"Infect Drug Resist"},{"key":"2024060223524129500_dkae116-B108","doi-asserted-by":"crossref","first-page":"e389","DOI":"10.1016\/S2352-3018(20)30099-0","article-title":"Fixed-dose combination bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir-containing regimens for initial treatment of HIV-1 infection: week 144 results from two randomised, double-blind, multicentre, phase 3, non-inferiority trials","volume":"7","author":"Orkin","year":"2020","journal-title":"Lancet HIV"},{"key":"2024060223524129500_dkae116-B109","doi-asserted-by":"crossref","first-page":"749948","DOI":"10.3389\/fnut.2022.749948","article-title":"Vitamin D and calcium supplementation reverses tenofovir-caused bone mineral density loss in people taking ART or PrEP: a systematic review and meta-analysis","volume":"9","author":"Bi","year":"2022","journal-title":"Front Nutr"},{"key":"2024060223524129500_dkae116-B110","doi-asserted-by":"crossref","first-page":"815","DOI":"10.7326\/M14-1409","article-title":"Vitamin D and calcium attenuate bone loss with antiretroviral therapy initiation: a randomized trial","volume":"162","author":"Overton","year":"2015","journal-title":"Ann Intern Med"},{"key":"2024060223524129500_dkae116-B111","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3851\/IMP3346","article-title":"The effect of tenofovir disoproxil fumarate on bone mineral density: a systematic review and meta-analysis","volume":"25","author":"Baranek","year":"2020","journal-title":"Antivir Ther"},{"key":"2024060223524129500_dkae116-B112","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1093\/infdis\/jiv194","article-title":"Changes in bone mineral density after initiation of antiretroviral treatment with tenofovir disoproxil fumarate\/emtricitabine plus atazanavir\/ritonavir, darunavir\/ritonavir, or raltegravir","volume":"212","author":"Brown","year":"2015","journal-title":"J Infect Dis"},{"key":"2024060223524129500_dkae116-B113","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1177\/09564624221130129","article-title":"A retrospective analysis of bone loss in tenofovir-emtricitabine therapy for HIV PrEP","volume":"33","author":"Chang","year":"2022","journal-title":"Int J STD AIDS"},{"key":"2024060223524129500_dkae116-B114","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S2055-6640(20)30248-X","article-title":"Tenofovir alafenamide versus tenofovir disoproxil fumarate: is there a true difference in efficacy and safety?","volume":"4","author":"Hill","year":"2018","journal-title":"J Virus Erad"},{"key":"2024060223524129500_dkae116-B115","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/hiv.13061","article-title":"Outcomes associated with treatment change from tenofovir disoproxil fumarate to tenofovir alafenamide in HIV-1-infected patients: a real-world study in Japan","volume":"22","author":"Kanda","year":"2021","journal-title":"HIV Med"},{"key":"2024060223524129500_dkae116-B116","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1111\/hiv.12664","article-title":"Switching to coformulated rilpivirine (RPV), emtricitabine (FTC) and tenofovir alafenamide from either RPV, FTC and tenofovir disoproxil fumarate (TDF) or efavirenz, FTC and TDF: 96-week results from two randomized clinical trials","volume":"19","author":"Hagins","year":"2018","journal-title":"HIV Med"},{"key":"2024060223524129500_dkae116-B117","doi-asserted-by":"crossref","first-page":"e655","DOI":"10.1016\/S2352-3018(19)30195-X","article-title":"Bone mineral density in virologically suppressed people aged 60 years or older with HIV-1 switching from a regimen containing tenofovir disoproxil fumarate to an elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide single-tablet regimen: a multicentre, open-label, phase 3b, randomised trial","volume":"6","author":"Maggiolo","year":"2019","journal-title":"Lancet HIV"},{"key":"2024060223524129500_dkae116-B118","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/QAD.0000000000001725","article-title":"Switch from tenofovir disoproxil fumarate combination to dolutegravir with rilpivirine improves parameters of bone health","volume":"32","author":"McComsey","year":"2018","journal-title":"AIDS"},{"key":"2024060223524129500_dkae116-B119","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/hiv.12961","article-title":"Bone mineral density, kidney function, weight gain and insulin resistance in women who switch from TDF\/FTC\/NNRTI to ABC\/3TC\/DTG","volume":"22","author":"Ibrahim","year":"2021","journal-title":"HIV Med"},{"key":"2024060223524129500_dkae116-B120","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1089\/aid.2020.0274","article-title":"Re: \u201cNo significant changes in weight and body fat mass in suppressed HIV infected patients switched to dual combination lamivudine plus dolutegravir or raltegravir\u201d by Calza et al","volume":"37","author":"Ciccullo","year":"2021","journal-title":"AIDS Res Hum Retroviruses"},{"key":"2024060223524129500_dkae116-B121","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1007\/s11357-011-9311-8","article-title":"Exercise effects on bone mineral density in older adults: a meta-analysis of randomized controlled trials","volume":"34","author":"Marques","year":"2012","journal-title":"Age (Dordr)"},{"key":"2024060223524129500_dkae116-B122","first-page":"741639","article-title":"Exercise and bone mineral density in premenopausal women: a meta-analysis of randomized controlled trials","volume":"2013","author":"Kelley","year":"2013","journal-title":"Int J Endocrinol"},{"key":"2024060223524129500_dkae116-B123","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1089\/jwh.2006.15.1141","article-title":"Impact of smoking cessation on bone mineral density in postmenopausal women","volume":"15","author":"Oncken","year":"2006","journal-title":"J Womens Health (Larchmt)"},{"key":"2024060223524129500_dkae116-B124","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3390\/nu10010097","article-title":"Specific collagen peptides improve bone mineral density and bone markers in postmenopausal women\u2014a randomized controlled study","volume":"10","author":"K\u00f6nig","year":"2018","journal-title":"Nutrients"},{"key":"2024060223524129500_dkae116-B125","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/ageing\/afy169","article-title":"Sarcopenia: revised European consensus on definition and diagnosis","volume":"48","author":"Cruz-Jentoft","year":"2019","journal-title":"Age Ageing"},{"key":"2024060223524129500_dkae116-B126","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1111\/jgs.16372","article-title":"Sarcopenia definition: the position statements of the Sarcopenia Definition and Outcomes Consortium","volume":"68","author":"Bhasin","year":"2020","journal-title":"J Am Geriatr Soc"},{"key":"2024060223524129500_dkae116-B127","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S2213-8587(14)70034-8","article-title":"Age-related and disease-related muscle loss: the effect of diabetes, obesity, and other diseases","volume":"2","author":"Kalyani","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2024060223524129500_dkae116-B128","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1080\/17425255.2019.1667334","article-title":"Drug-drug interactions when treating HIV-related metabolic disorders","volume":"15","author":"Gutierrez","year":"2019","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"2024060223524129500_dkae116-B129","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1093\/jac\/dkaa099","article-title":"Real-life management of drug-drug interactions between antiretrovirals and statins","volume":"75","author":"Courlet","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"2024060223524129500_dkae116-B130","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/2042018814559725","article-title":"GLP-1 receptor agonists: a review of head-to-head clinical studies","volume":"6","author":"Trujillo","year":"2015","journal-title":"Ther Adv Endocrinol Metab"},{"key":"2024060223524129500_dkae116-B131","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1093\/ofid\/ofad500.109","article-title":"GLP-1 receptor agonists promote weight loss among people with HIV","volume":"10","author":"Nguyen","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"2024060223524129500_dkae116-B132","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1161\/CIRCULATIONAHA.117.028975","article-title":"Cardiovascular risk prediction functions underestimate risk in HIV infection","volume":"137","author":"Triant","year":"2018","journal-title":"Circulation"},{"key":"2024060223524129500_dkae116-B133","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1468-1293.2006.00362.x","article-title":"The use of the Framingham equation to predict myocardial infarctions in HIV-infected patients: comparison with observed events in the D:A:D study","volume":"7","author":"Law","year":"2006","journal-title":"HIV Med"},{"key":"2024060223524129500_dkae116-B134","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/cid\/ciu701","article-title":"Cross-sectional comparison of the prevalence of age-associated comorbidities and their risk factors between HIV-infected and uninfected individuals: the AGEhIV cohort study","volume":"59","author":"Schouten","year":"2014","journal-title":"Clin Infect Dis"},{"key":"2024060223524129500_dkae116-B135","doi-asserted-by":"crossref","first-page":"e0236177","DOI":"10.1371\/journal.pone.0236177","article-title":"Cardiovascular disease risk among transgender women living with HIV in the United States","volume":"15","author":"Gosiker","year":"2020","journal-title":"PLoS ONE"},{"key":"2024060223524129500_dkae116-B136","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S2213-8587(21)00185-6","article-title":"Mortality trends over five decades in adult transgender people receiving hormone treatment: a report from the Amsterdam cohort of gender dysphoria","volume":"9","author":"de Blok","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2024060223524129500_dkae116-B137","doi-asserted-by":"crossref","first-page":"ofab011","DOI":"10.1093\/ofid\/ofab011","article-title":"Hot flashes and cardiovascular disease risk indices among women with HIV","volume":"8","author":"Toribio","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"2024060223524129500_dkae116-B138","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s11904-016-0301-4","article-title":"Recent insights into cardiovascular disease (CVD) risk among HIV-infected adults","volume":"13","author":"Kaplan","year":"2016","journal-title":"Curr HIV\/AIDS Rep"},{"key":"2024060223524129500_dkae116-B139","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/COH.0000000000000407","article-title":"Tobacco, illicit drugs use and risk of cardiovascular disease in patients living with HIV","volume":"12","author":"Raposeiras-Roub\u00edn","year":"2017","journal-title":"Curr Opin HIV AIDS"},{"key":"2024060223524129500_dkae116-B140","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1056\/NEJMoa2304146","article-title":"Pitavastatin to prevent cardiovascular disease in HIV infection","volume":"389","author":"Grinspoon","year":"2023","journal-title":"N Engl J Med"},{"key":"2024060223524129500_dkae116-B141","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1111\/hiv.12378","article-title":"Fall frequency and associated factors among men and women with or at risk for HIV infection","volume":"17","author":"Erlandson","year":"2016","journal-title":"HIV Med"},{"key":"2024060223524129500_dkae116-B142","doi-asserted-by":"crossref","first-page":"101348","DOI":"10.1016\/j.arr.2021.101348","article-title":"A systematic review of biological, social and environmental factors associated with epigenetic clock acceleration","volume":"69","author":"Oblak","year":"2021","journal-title":"Ageing Res Rev"},{"key":"2024060223524129500_dkae116-B143","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/QAI.0000000000002955","article-title":"Polypharmacy is associated with falls in women with and without HIV","volume":"90","author":"Psomas","year":"2022","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2024060223524129500_dkae116-B144","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1080\/09540121.2017.1384532","article-title":"Polypharmacy and risk of falls and fractures for patients with HIV infection and substance dependence","volume":"30","author":"Kim","year":"2018","journal-title":"AIDS Care"},{"key":"2024060223524129500_dkae116-B145","author":"Panel on Antiretroviral Guidelines for Adults and Adolescents"},{"key":"2024060223524129500_dkae116-B146","author":"World Health Organization"},{"key":"2024060223524129500_dkae116-B147","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s11904-019-00464-3","article-title":"Aging with HIV","volume":"16","author":"Guaraldi","year":"2019","journal-title":"Curr HIV\/AIDS Rep"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/79\/6\/1218\/58036563\/dkae116.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/79\/6\/1218\/58036563\/dkae116.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,2]],"date-time":"2024-06-02T19:55:20Z","timestamp":1717358120000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/79\/6\/1218\/7657605"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,24]]},"references-count":147,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,4,24]]},"published-print":{"date-parts":[[2024,6,3]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkae116","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,6]]},"published":{"date-parts":[[2024,4,24]]}}}